Cerebrolysin: Side Effects & Safety
Part of the Cerebrolysin Complete Guide
Partner
Shop Peptides at BioLongevity LabsResearch Peptides
BioLongevity Labs15% Off
Advertiser link — we may earn a commission at no extra cost to you.
Common Side Effects
Cerebrolysin has a favorable safety profile with most side effects mild and transient:
| Side Effect | Frequency | Severity | Management |
|---|---|---|---|
| Injection site pain (IM) | Common (10–20%) | Mild | Rotate sites, split large volumes |
| Headache | Occasional (5–10%) | Mild | Resolves within hours |
| Dizziness | Occasional (3–8%) | Mild | Transient; more common during IV |
| Nausea | Uncommon (2–5%) | Mild | Eat before treatment |
| Insomnia | Uncommon (1–3%) | Mild | Administer in morning |
| Agitation | Rare (1–2%) | Mild–moderate | More common in dementia patients |
In CASTA and CARS trials, adverse event rates in the Cerebrolysin group were comparable to placebo.
Serious & Rare Side Effects
- Allergic reactions: Cerebrolysin is porcine-derived. Patients with hypersensitivity to pork products should not use it. Anaphylaxis is extremely rare
- Seizures: Theoretical concern about seizure threshold lowering in patients with pre-existing epilepsy
- Fever: Rarely reported; may indicate immune response to porcine peptides
- Cardiovascular: No significant cardiovascular adverse events attributed to Cerebrolysin in clinical trials
Serious adverse event rates were not significantly different between Cerebrolysin and placebo in both CARS (n=208) and CASTA (n=1,070) trials.
Contraindications & Precautions
Cerebrolysin should not be used in:
- Epilepsy: Particularly uncontrolled seizure disorders. Status epilepticus is a specific contraindication
- Severe renal impairment
- Allergic diathesis: History of severe reactions to porcine-derived products
- Pregnancy and breastfeeding: Safety not established
Precautions:
- Monitor for hypersensitivity during first administration
- IV infusion should be slow (15–60 minutes)
- Do not mix with solutions containing divalent cations (calcium, magnesium)
Safety vs. Alternative Nootropics
- vs. Semax: Semax is intranasal with minimal side effects. Cerebrolysin requires injection with injection-site reactions and rare allergic risk
- vs. Dihexa: Dihexa has very limited human safety data. Cerebrolysin has decades of clinical use across thousands of patients
- vs. Selank: Selank is intranasal with minimal side effects and different mechanism (anxiolytic + immune modulation)
Return to the Cerebrolysin overview or see the dosage guide.